
### [NCIT:C7074](http://purl.obolibrary.org/obo/NCIT_C7074)
**Label:** Serous Neoplasm

**Subclasses:** [NCIT:C5724](http://purl.obolibrary.org/obo/NCIT_C5724) (Pancreatic Serous Cystadenocarcinoma), [NCIT:C3783](http://purl.obolibrary.org/obo/NCIT_C3783) (Serous Cystadenoma), [NCIT:C4511](http://purl.obolibrary.org/obo/NCIT_C4511) (Ovarian Serous Cystadenoma), [NCIT:C105556](http://purl.obolibrary.org/obo/NCIT_C105556) (Low Grade Ovarian Serous Adenocarcinoma), [NCIT:C105555](http://purl.obolibrary.org/obo/NCIT_C105555) (High Grade Ovarian Serous Adenocarcinoma), [NCIT:C6256](http://purl.obolibrary.org/obo/NCIT_C6256) (Ovarian Serous Surface Papillary Adenocarcinoma), [NCIT:C40029](http://purl.obolibrary.org/obo/NCIT_C40029) (Borderline Ovarian Serous Cystadenofibroma), [NCIT:C132294](http://purl.obolibrary.org/obo/NCIT_C132294) (Recurrent Endometrial Serous Adenocarcinoma), [NCIT:C8431](http://purl.obolibrary.org/obo/NCIT_C8431) (Ovarian Serous Tumor), [NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor), [NCIT:C40028](http://purl.obolibrary.org/obo/NCIT_C40028) (Borderline Ovarian Serous Adenofibroma), [NCIT:C40025](http://purl.obolibrary.org/obo/NCIT_C40025) (Malignant Ovarian Serous Tumor), [NCIT:C40102](http://purl.obolibrary.org/obo/NCIT_C40102) (Fallopian Tube Serous Neoplasm), [NCIT:C126449](http://purl.obolibrary.org/obo/NCIT_C126449) (Serous Tubal Intraepithelial Carcinoma), [NCIT:C40023](http://purl.obolibrary.org/obo/NCIT_C40023) (Primary Peritoneal Serous Adenocarcinoma), [NCIT:C40101](http://purl.obolibrary.org/obo/NCIT_C40101) (Serous Adenocarcinoma), [NCIT:C126481](http://purl.obolibrary.org/obo/NCIT_C126481) (High Grade Broad Ligament Serous Adenocarcinoma), [NCIT:C126480](http://purl.obolibrary.org/obo/NCIT_C126480) (Low Grade Broad Ligament Serous Adenocarcinoma), [NCIT:C7278](http://purl.obolibrary.org/obo/NCIT_C7278) (Ovarian Papillary Cystadenoma), [NCIT:C95476](http://purl.obolibrary.org/obo/NCIT_C95476) (Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma), [NCIT:C95475](http://purl.obolibrary.org/obo/NCIT_C95475) (Pancreatic Solid Serous Adenoma), [NCIT:C7313](http://purl.obolibrary.org/obo/NCIT_C7313) (Benign Ovarian Serous Tumor), [NCIT:C7279](http://purl.obolibrary.org/obo/NCIT_C7279) (Ovarian Surface Papilloma), [NCIT:C95471](http://purl.obolibrary.org/obo/NCIT_C95471) (Pancreatic Macrocystic Serous Cystadenoma), [NCIT:C95470](http://purl.obolibrary.org/obo/NCIT_C95470) (Pancreatic Serous Adenoma), [NCIT:C7550](http://purl.obolibrary.org/obo/NCIT_C7550) (Ovarian Serous Adenocarcinoma), [NCIT:C40136](http://purl.obolibrary.org/obo/NCIT_C40136) (Uterine Ligament Serous Adenocarcinoma), [NCIT:C126456](http://purl.obolibrary.org/obo/NCIT_C126456) (High Grade Fallopian Tube Serous Adenocarcinoma), [NCIT:C40099](http://purl.obolibrary.org/obo/NCIT_C40099) (Fallopian Tube Serous Adenocarcinoma), [NCIT:C126457](http://purl.obolibrary.org/obo/NCIT_C126457) (Low Grade Fallopian Tube Serous Adenocarcinoma), [NCIT:C67092](http://purl.obolibrary.org/obo/NCIT_C67092) (Ovarian Serous Adenocarcinofibroma), [NCIT:C67090](http://purl.obolibrary.org/obo/NCIT_C67090) (Serous Adenofibroma), [NCIT:C5226](http://purl.obolibrary.org/obo/NCIT_C5226) (Borderline Ovarian Serous Tumor), [NCIT:C27838](http://purl.obolibrary.org/obo/NCIT_C27838) (Endometrial Serous Adenocarcinoma), [NCIT:C8377](http://purl.obolibrary.org/obo/NCIT_C8377) (Papillary Serous Cystadenocarcinoma), [NCIT:C4177](http://purl.obolibrary.org/obo/NCIT_C4177) (Borderline Serous Cystadenoma), [NCIT:C40201](http://purl.obolibrary.org/obo/NCIT_C40201) (Cervical Serous Adenocarcinoma), [NCIT:C4180](http://purl.obolibrary.org/obo/NCIT_C4180) (Papillary Serous Cystadenoma), [NCIT:C126469](http://purl.obolibrary.org/obo/NCIT_C126469) (Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor), [NCIT:C5712](http://purl.obolibrary.org/obo/NCIT_C5712) (Pancreatic Serous Cystadenoma), [NCIT:C7978](http://purl.obolibrary.org/obo/NCIT_C7978) (Ovarian Serous Cystadenocarcinoma), [NCIT:C3778](http://purl.obolibrary.org/obo/NCIT_C3778) (Serous Cystadenocarcinoma), [NCIT:C7695](http://purl.obolibrary.org/obo/NCIT_C7695) (Primary Peritoneal Serous Papillary Adenocarcinoma), [NCIT:C4182](http://purl.obolibrary.org/obo/NCIT_C4182) (Serous Surface Papillary Carcinoma), [NCIT:C4183](http://purl.obolibrary.org/obo/NCIT_C4183) (Borderline Papillary Serous Cystadenoma), [NCIT:C41248](http://purl.obolibrary.org/obo/NCIT_C41248) (Pancreatic Serous Neoplasm), [NCIT:C40113](http://purl.obolibrary.org/obo/NCIT_C40113) (Fallopian Tube Serous Adenofibroma), [NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma), [NCIT:C126478](http://purl.obolibrary.org/obo/NCIT_C126478) (Broad Ligament Serous Adenofibroma), [NCIT:C40032](http://purl.obolibrary.org/obo/NCIT_C40032) (Ovarian Serous Cystadenofibroma), [NCIT:C126477](http://purl.obolibrary.org/obo/NCIT_C126477) (Broad Ligament Serous Cystadenofibroma), [NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma), [NCIT:C40031](http://purl.obolibrary.org/obo/NCIT_C40031) (Ovarian Serous Adenofibroma), [NCIT:C126479](http://purl.obolibrary.org/obo/NCIT_C126479) (Broad Ligament Serous Adenocarcinoma), [NCIT:C126353](http://purl.obolibrary.org/obo/NCIT_C126353) (Primary Peritoneal High Grade Serous Adenocarcinoma), [NCIT:C126476](http://purl.obolibrary.org/obo/NCIT_C126476) (Broad Ligament Serous Cystadenoma), [NCIT:C126354](http://purl.obolibrary.org/obo/NCIT_C126354) (Primary Peritoneal Low Grade Serous Adenocarcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C37115](http://purl.obolibrary.org/obo/NCIT_C37115) (Serous Adenocarcinoma Cell))) 75.00%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell))) 75.00%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C36794](http://purl.obolibrary.org/obo/NCIT_C36794) (Dysplastic Glandular Cell))) 75.00%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell))) 75.00%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C36773](http://purl.obolibrary.org/obo/NCIT_C36773) (Adenocarcinoma Cell))) 75.00%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell))) 75.00%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 60.36%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([CHEBI:16336](http://purl.obolibrary.org/obo/CHEBI_16336) (hyaluronic acid))) 60.36%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([CHEBI:15440](http://purl.obolibrary.org/obo/CHEBI_15440) (squalene))) 60.36%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([CHEBI:10545](http://purl.obolibrary.org/obo/CHEBI_10545) (electron))) 60.36%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not (CARO:0010000)) 60.36%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([BFO:0000020](http://purl.obolibrary.org/obo/BFO_0000020) (null))) 60.36%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([BFO:0000019](http://purl.obolibrary.org/obo/BFO_0000019) (null))) 60.36%
- [NCIT:C36764](http://purl.obolibrary.org/obo/NCIT_C36764) (Abnormal Glandular Cell) 59.05%
- [NCIT:C36763](http://purl.obolibrary.org/obo/NCIT_C36763) (Neoplastic Glandular Cell) 59.05%


